Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2002

Shaw JA, Udokang K, Mosquera J-, Chauhan H, J Jones L, Walker RA. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol. 2002;198(4):450-7.

Sellers WR, Loda M. The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? Cancer Cell. 2002;2(5):349-50.

Ince TA, Weinberg RA. Functional genomics and the breast cancer problem. Cancer Cell. 2002;1(1):15-7.

Magro CM, Deng A, Pope-Harman A, W Waldman J, A Collins B, Adams PW, et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation. 2002;74(9):1273-80.

Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL, Saatcioglu F. Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem. 2002;277(39):36689-96.

Ponting CP, Ito T, Moscat J, Diaz-Meco MT, Inagaki F, Sumimoto H. OPR, PC and AID: all in the PB1 family. Trends Biochem Sci. 2002;27(1):10.

Ding R, Medeiros M, Dadhania D, Muthukumar T, Kracker D, Kong JM, et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation. 2002;74(7):987-94.

Badgwell B, Parihar R, Magro C, Dierksheide J, Russo T, Carson WE. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery. 2002;132(2):205-12.

Oh WK, Loda M, Kantoff PW, Janicek M. Progressive sclerosis of isolated foot metastasis of prostate cancer. J Urol. 2002;167(3):1392.

Bai Y, Fu S, Honig S, Wang Y, Qin L, Chen D, et al. CD2 is a dominant target for allogeneic responses. Am J Transplant. 2002;2(7):618-26.